introduction: involvement of the skeleton can cause an excruciating pain in two-thirds of terminal patients with a history of malignancy. due to several limitations of other therapies, such as analgesics, bisphosphonates, chemotherapy, hormonal therapy and external beam radiotherapy; bone-seeking radiopharmaceuticals have an important role in palliation of pain from bone metastases. although th...

Radioactivity is the spontaneous emission of energy from unstable atoms. Radioactive sources have radionuclides. Radionuclide undergoes radioactive decay and emits gamma rays and subatomic particles, constituting the ionizing radiation. The gamma ray energy of a radionuclide is used to determine the identity of gamma emitters present in the source. This paper describes the hardware implementati...

Research Objectives: Microbiological reduction and immobilization of U(VI) and Tc(VII) has been proposed as a strategy for remediating radionuclide-contaminated environments. Numerous studies focusing on the reduction kinetics and speciation of these metals have been carried out using contaminated sediment samples, microbial consortia, and pure bacterial cultures. While previous work with model...

background: this study consists of two parts. the first part deals with both qualitative and quantitative analysis of 226ra using alpha spectrometry measurement method. in the second part, the percentage of radioactive equilibrium between 226 ra and its daughter products were determined by alpha spectrometry and total alpha measurement system after elapsed time of 15 days from precipitation. ma...

Radionuclide ventriculography is an accepted method for diagnosing left ventricular aneurysms, but false-negative studies have been associated with a mural thrombus filling the left ventricular cavity. We describe a patient with a left ventricular aneurysm due to myocardial infarction whose aneurysm scintigraphically "disappeared" from serial radionuclide ventriculograms. This was documented ec...

Targeted radionuclide therapy is one of the most intensively developing directions of nuclear medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy causes less collateral damage to normal tissues and allows targeted drug delivery to a clinically diagnosed neoplastic malformations, as well as metastasized cells and cellular clusters, thus providing systemic thera...